This episode is part of our Top 5 Most-Watched series—featuring standout conversations that originally aired on Heart Rhythm TV and have continued to resonate with the EP community.
Given the recent FDA approval of multiple PFA technologies for the ablation of atrial fibrillation, Heart Rhythm TV presents a summary of the current science of the efficacy and safety of PFA as many are adopting this new technology in their practices. #HRStv host Daniel M. Alyesh, MD, FHRS, sits down with Roderick Tung, MD, FHRS, and Atul Verma, MD, FHRS to review the following –
• Summaries of the efficacies in the major clinical trials, as well as safety events in the trials and registries.
• Issues with hemolysis and vasospasm in detail.
• Data on ICE guidance and modulation of autonomics.
Listen on:
Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
Resource Type
- HRStv Podcast
Related Resources
HRStv Podcast
Episode 125: Unlocking Antiarrhythmics From ABCs to Action — Foundations First: AAD Classes & Safety
January 9, 2026
HRStv Podcast
Episode 124: Ablation in ASCs 2026
January 8, 2026
HRStv Podcast
Episode 123: Cardiac Contractility Modulation Therapy in 2025
January 7, 2026